Your Vote Counts (Deadline: April 13)

March 31, 2025 Kigali, Rwanda and San Francisco, USA

SOCAP is the world’s largest annual impact event, providing change makers, entrepreneurs and institutional investors the opportunity to learn from each other and forge powerful connections. Conference sessions are designed to be engaging and solution-oriented, and are chosen by a competitive process, the SOCAP OPEN.

Bio Usawa is proud to be among those selected to advance into the community voting stage on the basis of its proposal to convene a panel addressing health equity entitled: “Just Medicine: Bringing Healthcare Justice and Equity to Africa and Beyond”.

We encourage you to visit our panel summary and thank you in advance for your vote!

Just Medicine Panel for SOCAP

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.